Glycated albumin to glycated hemoglobin ratio is a sensitive indicator of blood glucose variability in patients with fulminant type 1 diabetes

Internal Medicine

Volumn 51, Issue 11, 2012, Pages 1315-1321

  Matsumoto, Hiroaki ^a   Murase Mishiba, Yuko ^a   Yamamoto, Naomune ^a   Sugitatsu Nakatsukasa, Saya ^a   Shibasaki, Saeko ^a   Sano, Hiroyuki ^a   Terasaki, Jungo ^a   Imagawa, Akihisa ^a   Hanafusa, Toshiaki ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Fulminant type 1 diabetes; Glucose variability; Glycated albumin; Type 1 diabetes

Indexed keywords

C PEPTIDE; CREATININE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; INSULIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD GLUCOSE VARIABILITY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCOSYLATED ALBUMIN HEMOGLOBIN A1C RATIO; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEAN AMPLITUDE OF GLUCOSE EXCURSION;

ADULT; AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; SERUM ALBUMIN;

EID: 84863086431     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.7236     Document Type: Article

References (29)

1. Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A. Correlation of glucose regulation and hemoglobin A1C in diabetes mellitus. N Engl J Med 295: 417-420, 1976.
2. Bunn HF, Gabbay KH, Gallop PM. The glycosylation of hemoglobin: relevance to diabetes mellitus. Science 20: 21-27, 1978.
3. Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 122: 561-568, 1995.
4. Diabetes Control and Complications Trial; Epidemiology of Diabetes Interventions and Complications Research Group. Intensive diabetes therapy and carotid intima-media thickness in Type 1 diabetes mellitus. N Engl J Med 348: 2294-2303, 2003.
5. Hanefeld M, Fisher D, Julius U, et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 39: 1577-1583, 1996.
6. Bonora E, Muggeo M. Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence. Diabetologia 44: 2107-2114, 2001.
7. Watada H, Azuma K, Kawamori R. Glucose fluctuation on the progression of diabetic macroangiopathy -New findings from monocyte adhesion to endothelial cells. Diabetes Res Clin Pract 77: S58-S61, 2007.
8. Snell-Bergeon JK, Roman R, Rodbard D, et al. Glycaemic variability is associated with coronary artery calcium in men with type 1 diabetes: the coronary artery calcification in type 1 diabetes study. Diabet Med 27: 1236-1242, 2010.
9. Jin WL, Azuma K, Mita T, et al. Repetitive hypoglycaemia increases serum adhesion adrenaline an induces monocyte adhesion to the endothelium in rat thoracic aorta. Diabetologia 54: 1921-1929, 2011.
10. Derr R, Garrett E, Stacy GA, Saudek CD. Is HbA1C affected by glycemic instability? Diabetes Care 26: 2728-2733, 2003.
11. Guthrow CE, Morris MA, Day JF, Thorpe SR, Baynes JW. Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus. Proc Natl Acad Sci USA 76: 4258-4261, 1979.
12. Day JF, Ingebretsen CG, Ingebretsen WR, Baynes JW, Thorpe SR. Nonenzymatic glycosylation of serum protein and hemoglobin: response to changes in blood glucose levels in diabetic rats. Diabetes 29: 524-527, 1980.
13. Yoshiuchi K, Matsuhisa M, Katakami N, et al. Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes. Endocr J 55: 503-507, 2008.
14. Saisho Y, Tanaka K, Abe T, Shimada A, Kawai T, Itoh H. Gly-cated albumin to glycated hemoglobin ratio reflects postprandial glucose excursion and relates to beta cell function in both type 1 and type 2 diabetes. Diabetol Int 2: 146-153, 2011.
15. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. A novel subtype of Type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group. N Engl J Med 342: 301-307, 2000.
16. Imagawa A, Hanafusa T, Uchigata Y, et al. Fulminant Type 1 diabetes: a nationwide survey in Japan. Diabetes Care 26: 2345-2352, 2003.
17. Imagawa A, Hanafusa T. Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners. Nat Clin Prac Endocrinol Metab 3: 36-45, 2007.
18. Kobayashi T, Tamemoto K, Nakanishi K, et al. Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care 16: 780-788, 1993.
19. Kawabata Y, Ikegami H, Awata T, et al. Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset. Diabetologia 52: 2513-2521, 2009.
20. Moberg EA, Lins PE, Adamson UK. Variability of blood glucose levels in patients with Type 1 diabetes mellitus on intensified insulin regimens. Diab Metab 6: 546-552, 1994.
21. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care 27(Suppl 1): S15-S35, 2004.
22. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 19: 644-655, 1970.
23. Murase Y, Imagawa A, Makino H, et al. Fulminant type 1 diabetes as a high risk group for diabetic microangiopathy-a nationwide 5-year-study in Japan. Diabetologia 50: 531-537, 2007.
24. Imai T, Oikawa Y, Shimada A. Improved monitoring of the hyper-glycemic state in type 1 diabetes patients by use of the glycoalbu-min/HbA1c Ratio. Rev Diabet Stud 4: 44-48, 2007.
25. Garlick RL, Mazer JS. The principal site of nonenzymatic glyco-sylation of human serum albumin in vivo. J Biol Chem 258: 6142-6146, 1983.
26. Jones IR, Owens DR, Hayes TM, et al. Glycosylated serum albumin: an intermediate index of diabetic control. Diabetes Care 5: 501-503, 1983.
27. Schleicher ED, Olgemllöer B, Wiedenmann E, Gerbitz KD. Specific glycation of albumin depends on its half-life. Clin Chem 39: 625-628, 1993.
28. Virtue MA, Furne JK, Nuttall FQ, et al. Relationship between GHb concentration and erythrocyte survival determined from breath carbon monoxide concentration. Diabetes Care 27: 931-935, 2004.
29. Goldstein DE, Little RR, Lorenz RA, et al. Tests of glycemia in diabetes. Diabetes Care 27: 1761-1773, 2004.